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Summary
Classically, osteoarthritis (OA) has been considered a noninflammatory disease . However, the
detection of selected inflammatory mediators in osteoarthritic fluid, in the absence of significant
inflammatory cell infiltrate, is increasingly appreciated. We sought to identify the inflammatory
component in human OA-affected cartilage that may be involved in cartilage damage/destruc-
tion . Using Western blot analysis and an antibody to the conserved region ofnitric oxide syn-
thase (NOS), we have observed up-regulation ofNOS, one of the "key players" of inflamma-
tion, in chondrocytes of OA-affected patients . Remarkably, none of the cartilage samples
examined from normal joints demonstrated detectable amounts of this NOS . Western blot
analysis using the same ot-NOS antibody indicated that this NOS from OA-affected cartilage
(OA-NOS) was larger in size than (and distinct from) transfected human hepatocyte or murine
inducible NOS (iNOS) (150 versus 133 kD) and similar in size to neuronal constitutive NOS
(ncNOS) . Antibodies specific for iNOS showed binding to murine and human iNOS but not
to OA-NOS, endothelial constitutive NOS, or ncNOS . Antibodies specific for ncNOS bound
to ncNOS and also to OA-NOS, but not to murine or human iNOS or endothelial constitu-
tive NOS . Incubation ofOA cartilage in serum-free medium resulted in spontaneous release,
for up to 72 h, of substantial amounts of nitrite (up to ^"80 RM/100 mg wet tissue), which
could be inhibited by at least 80% with various inhibitors of iNOS, including inhibitors ofpro-
tein synthesis and transcription factor NF-KB, but which (unlike murine macrophage iNOS)
was not sensitive to hydrocortisone or TGF-(3 . Exposure of OA-affected cartilage to interleu-
kin 1 R, tumor necrosis factor--(at, and lipopolysaccharide resulted in -20-50% augmentation of
nitrite accumulation, which was also sensitive to cycloheximide and pyrrolidine dithiocarba-
mate . Hence, our data indicate that OA-NOS (based on immunoreactivity and molecular
weight) is similar to ncNOS and that it releases nitric oxide, which may contribute to the in-
flammation and pathogenesis of cartilage destruction in OA.
O
steoarthritis or "osteoarthrosis" : Which term is more
appropriate? Classically, osteoarthritis (OA), unlike
rheumatoid arthritis (RA), is defined as an inherently non-
inflammatory disorder of movable joints characterized by
deterioration of articular cartilage and the formation ofnew
bone at the joint surfaces and margins (1) . In contrast to
RA, the synovial fluid in OA typically contains few neu-
trophils (<3,000/mm 3 ), and, except for advanced disease,
the synovium does not exhibit significant cellular prolifera-
tion or infiltration by inflammatory leukocytes . The mo-
lecular pathogenesis of OA is increasingly understood by
the elucidation of events within the articular cartilage . For
example, altered dynamic equilibrium between matrix syn-
thesis and degradation by human chondrocytes has recently
been implicated as having a primary role in the degenera-
tion of articular cartilage resulting in OA (2, 3) . This in-
cludes up-regulation of catabolic activities, such as secre-
tion of degradative proteases, and/or down-regulation of
anabolic activities such as collagen and proteoglycan syn-
thesis (2, 3) . Cytokines such as IL-1 and TNF, which in-
duce nitric oxide (NO) production in human chondrocytes
(4), have also been implicated in the destruction of cartilage
in OA (3) .
In general, NO produced by the constitutive isoform of
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stasis, whereas the generation ofNO by the inducible NOS
(iNOS) plays an important role in inflammation, host de-
fense responses, and tissue repair (5) . iNOS has been found
in various cell types (5) . Exposure of rabbit (6) and human
chondrocytes (4, 5) to cytokines and endotoxin leads to ac-
cumulation of nitrite in the medium . Studies involving an-
imal arthritis models and analysis ofhuman synovial fluids
have implicated NO in the pathogenesis of arthritis (7, 8) .
Induction of arthritis in rodent models resulted in increased
production ofnitrite before the onset ofclinical symptoms .
The appearance of articular symptoms and joint degenera-
tion in these animal models could be inhibited by adminis-
tration of an NOS inhibitor (7) . Neuronal cNOS (ncNOS)
has been shown to be present in several cell types (5) . Its
function outside the vicinity of the neuronal system has re-
cently been recognized, where ncNOS-knockout mice
show abnormalities in the gastrointestinal tract similar to
pyloric stenosis (9) .
Increased concentrations of nitrite have been reported in
human synovial fluid from RA and OA patients, suggesting
that NO may be a mediator of inflammation in both dis-
eases (8) . In the present study, we sought to identify the
source ofNO in OA and to characterize the respective
NOS . In this paper, we report the following: (a) OA-NOS
expressed under pathological conditions is similar to ncNOS
(and distinct from iNOS) and is not detected in normal car-
tilage; (b) human OA cartilage spontaneously releases mi-
cromolar concentrations ofNO ; and (c) the prolonged (72-h)
accumulation ofNO by OA cartilage in ex vivo experi-
ments is indicative ofNO up-regulating factor(s) within
the cartilage, and this phenomenon is sensitive to inhibitors
of protein synthesis and of the transcription factor NF-KB,
but not to TGF-R or hydrocortisone .
Materials and Methods
Reagents and Cell Lines .
￿
A macrophage-like cell line, RAW
264 .7, was obtained from American Type Culture Collection
(Rockville, MD) . Monoclonal a-mouse macrophage iNOS Ab,
monoclonal a-human endothelial cNOS (ecNOS) Ab, and poly-
clonal a-human ncNOS Ab were obtained from Transduction
Laboratories (Lexington, KY) ; specific polyclonal a-mouse mac-
rophage iNOS Ab were from Affinity Bioreagents, Inc . (Ne-
shanic Station, NJ) ; protease inhibitors, hydrocortisone, cyclo-
heximide, pyrrolidine dithiocarbamate (PDTC), aminoguanidine
and LPS were from Sigma Chemical Co . (St . Louis, MO) ; human
IL-1(3, TGF-(3, and TNF-a were from Fisher Scientific Co .
(Pittsburgh, PA) ; and HN~-monomethyl-L-arginine monoace-
tate (L-NMMA) from Cyclo 3pss BioChemical Corp . (Salt Lake
City, UT) .
Isolation of Bovine Chondrocytes .
￿
Bovine cartilage was washed
after removing the perichondrium, cut into small pieces, and di-
gested with pronase (0.1%) in PBS for 30 min, followed by diges-
tion with collagenase P (0.1%) for 12-16 h in F-12 medium.
Cells were then washed and resuspended in the respective media
for experiments .
Extraction of Human Chondrocyte NOS and Western Blotting.
OA cartilage was obtained from OA patients who underwent
knee replacement surgery and were free ofsteroidal/nonsteroidal
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andinflammatory drugs for at least 2 wk before surgery ; nonar-
thritic normal knee cartilage was obtained from the Musculoskel-
etal Transplant Foundation (Shrewsbury, NJ) within 24 h ofdeath,
or from autopsies the same day. Slices from articular cartilage af-
fected by OA (and normal controls) were frozen at -70°C,
milled to fine particles in liquid nitrogen, and sequentially ex-
tracted (10 ml/g wet weight tissue) with neutral salt buffer (Tris-
HCl:saline) containing protease inhibitors (1 mM PMSF, 2 MM
N-ethylmaleimide, and 0.025 mg/ml leupeptin), followed with
the same buffer containing 10 mM EDTA, with 4 M guanidine-
HCl, and then with a detergent buffer containing 10% SDS with
protease inhibitors . Samples were run on 9% or 4-15% gradient
SDS-PAGE gels under nonreducing conditions, transferred to ni-
trocellulose, and Western blotted with the required a-NOS Ab .
Bound antibody was detected by a secondary antibody conju-
gated with horseradish peroxidase, and developed using the en-
hanced chemiluminescence Western blotting system (Amersham
Corp ., Arlington Heights, IL) on x-ray film (Xomatic; Eastman
Kodak Co ., Rochester, NY) .
Isolation of Recombinant Human Hepatocyte iNOS. Human
hepatocyte iNOS was obtained from 3T3 fibroblasts (National
Institutes of Health, Bethesda, MD) transduced with a retrovirus
carrying the human hepatocyte iNOS cDNA . The construction
and characterization of the stable expression of iNOS in these
cells have been reported by Tzeng et al . (10) .
Results and Discussion
We initiated our studies by standardizing conditions to
extract NOS directly from OA-affected articular cartilage
before cell isolation . OA cartilage was sequentially ex-
tracted with various buffers and Western blotted using a
monoclonal of-mouse macrophage iNOS Ab that cross-
reacts with human hepatocyte iNOS . Approximately 90%
of NOS from OA-affected cartilage (OA-NOS) was
present in the neutral salt fraction, -10% was seen in the
EDTA-containing buffer, and no OA-NOS was detected
in either the guanidine or detergent extracts (Fig. 1 a) .
To further evaluate the expression of OA-NOS, equal
amounts of extracts from OA-affected and nonarthritic ar-
ticular cartilage were subjected to Western blot analysis us-
ing the same a-mouse macrophage iNOS mAb . All 12 pa-
tients with OA demonstrated expression of a 150 kD NOS,
whereas no NOS was detected from nonarthritic control
cartilage (Fig . 1 b) . The OA-NOS detected in all 12 pa-
tients had a Mr of 150 kD, which was distinct from mouse
macrophage iNOS . This experiment demonstrates that, un-
der pathological conditions, the OA-affected cartilage ex-
presses an isoform ofNOS distinct in size from iNOS . The
absence ofNOS activity (nitrite release) in normal resting
human chondrocytes has also been reported by other inves-
tigators (4), in accord with our own observation that ex-
pression ofiNOS or OA-NOS is not detectable in normal
cartilage or chondrocytes .
The M r of the human OA-NOS was further compared
with other known isoforms ofNOS by Western blot anal-
ysis (Fig . 2) . At the same time, various antibodies were
tested for their cross-reactivity with OA-NOS and other
known isoforms of NOS . As expected, a monoclonal
a-mouse macrophage iNOS Ab (raised against the peptide
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(a) Western blot analysis ofNOS on 9% SDS-PAGE . Vari-
ous extracts from OA cartilage were prepared sequentially as described in
Materials and Methods . Lane 1, neutral salt extract; lane 2, EDTA extract;
lane 3, 4 M guanidine-HCI extract ; lane 4, detergent extract. (b) Neutral
salt extracts from knee articular cartilage of 12 OA patients (lanes 2-13)
and 7 nonarthritic (normal) individuals (lanes 14-20) . Lane 1 shows
iNOS from murine macrophages (RAW 264 .7) stimulated with LPS for
24 h . iNOS was detected with an a-murine macrophage iNOS mAb . Ex-
tracts were prepared from equal wet weight of cartilage samples, and
equal amounts were loaded in each lane .
sequence 961-1144), showed reactivity with 133-kD hu-
man hepatocyte iNOS and murine macrophage iNOS .
This monoclonal ot-mouse macrophage iNOS Ab also
bound to 150-kD human OA-NOS and rat ncNOS (Fig . 2
a), thus indicating that this ot-iNOS niAb also cross-reacts
with ncNOS . However, a polyclonal Ab raised against the
amino acid sequence 1095-1289 from human ncNOS
bound to 150-kD human OA-NOS (and also, as expected
to 150-kD rat ncNOS), but did not detect the 133 kD
iNOS (Fig. 2 b) . A polyclonal ot-mouse macrophage iNOS
Ab (raised from the peptide sequence 1131-1144) bound
to 133-kD mouse macrophage and human hepatocyte
iNOS, but not to 150-kD human OA-NOS or rat ncNOS
(Fig . 2 c) . None of these antibodies showed any reactivity
with extracts obtained from human umbilical vein endo-
thelial cells (HUVEC) . This HUVEC extract was tested by
probing it with an cx-ecNOS antibody, which showed a
133-kD ecNOS band (data not shown) . The monoclonal
a-mouse macrophage iNOS Ab also cross-reacts with
133-kD bovine and rodent chondrocyte iNOS (unpub-
lished data) . These results show that the 150-kD human
OA-NOS and ncNOS, which are similar in size (Fig. 2),
are distinct from iNOS from human hepatocytes (native
and transfected), humanB cells, bovine and rodent chondro-
cytes, and murine macrophages (10-12), which are 133 kD
(Fig . 2) . We conclude that the OA-NOS is similar to nc-
NOS, based on their similar size, their shared reactivity to
antibodies specific for 150 kD ncNOS, and their lack of re-
activity to polyclonal a-iNOS antibodies specific for the
133-kD iNOS .
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Western blotting of various cell extracts with antibodies to
NOS . Cell extracts from HUVEC, human OA cartilage (OA), hepato-
cyte iNOS transfected into 3T3 cells (HEPATOCYTE), rat brain
(BRAIN), and murine macrophages stimulated with 100 ng/ml LPS for
16 h (MACROPHAGE) were prepared and run on 5-15% SDS-PAGE
gel, and Western blotted with various antibodies as described in Materials
and Methods . Panels A, B, and C were probed with various a-NOS Ab
as described . The amino acid region from which each ofthese antibodies
was raised is designated in the figure as AA. The data represent one oftwo
identical representative experiments .
These observations pose an obvious question : What is
the role ofhuman chondrocyte iNOS in OA? It should be
noted that two groups (13, 14) have cloned the human
chondrocyte iNOS from cDNA libraries prepared from (in
vitro) IL-1-stimulated human chondrocytes . These librar-
ies were screened with a degenerative oligonucleotide or
murine iNOS cDNA . The OA-NOS seems to be distinct
from the human chondrocyte iNOS . Apparently, human
chondrocytes express at least two isoforms of NOS that
are differentially regulated, namely iNOS (13, 14) and
OA-NOS . Therefore, we propose that the known NO-
mediated chondrocyte dysfunction that could lead to OA is
the result of up-regulation ofOA-NOS .
To evaluate the biological activity of OA-NOS, we
standardized parameters to set up organ culture of OA-
affected cartilage in ex vivo conditions . We observed that
-50-100 mg ofOA cartilage from various patients released
^ "10-80 p,M of nitrite after 48 h in serum-free medium,
which could be inhibited by >90% with 500 p,M L-NMMA
(Fig . 3 a) or aminoguanidine (not shown) . Interestingly, in
a single case in which cartilage was obtained from both
knees, similar levels of nitrite were observed (Fig . 3 a, pa-
tient samples Nos . 3a and 3b) . These experiments suggest
that OA-affected chondrocytes generate micromolar con-
centrations ofNO that have been associated with degrada-
tion of articular cartilage (8) . Exposure of the OA cartilage
in vitro to pharmacological concentrations ofIL-10, TNF-ac,
and endotoxin resulted in a consistent increase inNO pro-
duction at 24 h (Fig. 3 b) and a more pronounced effect atb
￿
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Figure 3 .
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(a) Release ofnitrite byOA cartilage
in ex vivo conditions after 48 h . Knee artilc
cartilage from three OA patients was cut into 3-nun
discs ; 4-6 discs were placed in organ culture in 2
ml medium in the presence and absence (CON-
TROL) of 500 1t,M L-NMMA . 3a and 3b were
samples obtained from left and right knees ofthe
same patient . Data are expressed as 1LM nitrite re-
leased ± SD (n = 4) . The P values between
Control and L-NMMA-treated cultures were : 1
<0.013 ; 2 <0.002 ; 3a <0.066 ; 3b <0.048 . (b)
Release ofnitrite by OA cartilage in ex vivo con-
ditions after 24 h in the presence and absence of
LPS (100 Vg/ml), IL-1(3 (1 ng/ml), and TNF-(x
(1 ng/ml) . Knee articular cartilage from one OA
patient was cut into 3-mm discs; 3-4 discs were
placed in organ culture in 2 ml medium in the presence and absence (CONTROL) of500 pLM L-NMMA . One set of cultures was incubated with LPS,
IL-1 (3, and TNF-a . Data are expressed as micromoles of nitrite released ± SD (n = 7) . The P values between Control and L-NMMA-treated cultures
were : 4 <0.002 ; 5a <0.001 . The Pvalues between Control versus LPS-, IL-1(3-, and TNF-a-treated cultures were : 4 <0.0585 ; 5a <0.001 . (c) Release
ofnitrite by OA cartilage in ex vivo conditions after 48 h in the presence and absence of cytokines and endotoxin . The experiments were set up as de-
scribed in Fig . 3 b . Data are expressed as micromoles ofnitrite released ± SD (n = 4-7) . The P values between Control and L-NMMA-treated cultures
were : 6 <0.056 ; 7 <0.099; 5b <0.001 . The P values between Control versus LPS-, IL-1(3-, and TNF-a-treated cultures were : 6 <0.088 ; 7 <0.013 ;
5b <0.001 . Data obtained in 5a and 5b are from the same patient fromwhom the nitrite was sampled at 24 and 48 h, respectively. Samples obtained at
various time intervals were assayed for nitrite by modified Griess reaction (15) using an ELISA reader. The statistics were derived using unpaired Stu-
dent's t test.
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(a) Release ofnitrite by OA-affected articular cartilage in ex
vivo conditions at different time intervals . Knee articular cartilage from
OA patients was cut into 3-mm discs after surgery and placed in Hams-
F-12 media, with or without 1 mg/ml BSA, 10 mM Hepes, pH 7 .4, to-
gether with gentamicin and fungizone (GIBCO BRL, Gaithersburg,
MD) . Two discs were placed in 1 ml ofmedium in the presence and ab-
sence (CONTROL) of 500 ItM L-NMMA . Data are expressed as micro-
moles of nitrite released ± SD (n = 4-7) . The P values between the Con-
trol and L-NMMA-treated cultures for 24, 48, and 72 h were all <0.002 .
(b) Release of nitrite by OA cartilage in ex vivo conditions after 24 h in
the presence and absence (Control) of cycloheximide (35 ILM) and PDTC
(30 pLM) . OA cartilage was also incubated with LPS (100 lAg/ml), IL-1(3
(1 ng/ml), and TNF-et (1 ng/ml) in the presence and absence of equiva-
lent amounts of cycloheximide or PDTC . Data are expressed as micro-
moles of nitrite released ± SD (n = 4) . The P value between the Control
versus cycloheximide- and PDTC-treated cultures was <0.001 ; the P
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48 h (Fig. 3 c) . The spontaneous release ofNO could be
inhibited by L-NMMA as in Fig. 3, a and b . Snyder and co-
workers (16) have reported that neuronal NOS is induced
in spinal neurons by traumatic injury . Furthermore, human
chondrocytes exposed to exogenous NO, or cytokines and
endotoxin (at concentrations used in this study), have dem-
onstrated inhibition of growth, chemotactic responses to
growth factors, proteoglycan synthesis, and induction of
apoptosis (17-19, and unpublished data) . Therefore, it is
quite conceivable that the up-regulation of OA-NOS is
triggered under pathological conditions such as OA, be-
cause nitrite levels in the serum ofRA (0.44 ~tmol/liter)
and OA (0.21 ptmol/liter) patients were significantly ele-
vated in comparison to normal controls (0.14 pLmol/liter)
(8), whereas synovial fluids from these RA and OA patients
demonstrated significant mean nitrite levels of 0.91 and
0.35 Vll,mol/liter, respectively. It should be noted that, un-
like murine macrophages (11), human chondrocytes (10')
stimulated with cytokines and endotoxin in vitro release
nanomolar concentrations of nitrite (4, 20) .
To further investigate the regulation ofOA-NOS in OA
cartilage, a time course release of nitrite was performed .
OA cartilage incubated with serum-free medium demon-
strated a steady accumulation of nitrite up to 72 h (Fig . 4
a), indicating that production of nitrite is "spontaneously"
released and may be constantly stimulated in OA cartilage .
This nitrite production was inhibited by L-NMMA (Fig. 4 a) .
The spontaneous accumulation ofnitrite by OA-affected
cartilage was evaluated for its sensitivity to cycloheximide
and NF-KB inhibitor PDTC . Addition of3.5 and 17.5 N,M
value between cytokine plus endotoxin-treated cultures versus cyclohex-
imide/PDTC was <0.013 . Samples obtained at various time intervals
were assayed for nitrite by modified Griess reaction (15) using an ELISA
reader.
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Zofcycloheximide to OA cartilage showed >90% inhibition
of nitrite accumulation as compared with controls within
24 h. The data in Fig. 4 b show a representative experiment
in which addition of cytokines and endotoxin augmented
the release of nitrite in the medium. Nitrite accumulation
was significantly blocked by >90% in both the cytokine-
and endotoxin-induced cartilage and control cartilage in
the presence of cycloheximide or PDTC, thus indicating
that the OA-affected chondrocyte NOS activity is sensitive
to cycloheximide and PDTC with respect to production of
nitrite in ex vivo cultures. The inhibition by PDTC and
cycloheximide ofnitrite accumulation in OA cartilage may be
due to inhibition ofde novo protein synthesis of OA-NOS
itself, cofactors involved in the regulation of OA-NOS, or
both-a hypothesis that must be tested. However, it should
be noted that the human ncNOS gene has two NF-KB-
like sequences in the 5' untranslated region (21). Incuba-
tion of OA-affected articular cartilage, either in basal me-
dium alone or supplemented with BSA, had insignificant
impact on the release of nitrite (data not shown) . In similar
and parallel experiments using normal adult bovine articu-
lar cartilage or murine RAW 264.7 cells, we did not ob-
serve any detectable amounts (> 1 p,M) of nitrite after 48 h
(data not shown), indicating that the medium used in these
experiments was devoid of any stimulating agent that may
have contributed to the up-regulation of NOS in OA car-
tilage on days 2 and 3 in the ex vivo experiments. As ex-
pected, addition of LPS (100 ng/ml and 100 Ntg/ml)
showed an accumulation of nitrite in the medium after 20
or 48 h in both murine RAW 264.7 cells and bovine artic-
ular cartilage, respectively (data not shown) .
These studies also indicate that a PDTC/cycloheximide-
sensitive "NO-up-regulating factor(s)" may be present within
the OA cartilage. Potential up-regulator(s) ofOA-NOS may
be one or a combination of the following manifestations:
(a) autocrine cytokines/growth factors produced by chon-
drocytes in OA cartilage; (b) interaction with cell surface
receptor (glutamate receptors/CD53) or matrix compo-
nents (fibronectin and collagen) that can modulate NOS
(22, 23) ; (c) diffusion of soluble (paracrine) factors into the
cartilage in vivo from other cellular sources of the intraar-
ticular region (e.g., endothelial cells, lining of the synovial
capillaries, local inflammatory cells, and/or synovial fibro-
blasts) ; (d) abnormal mechanical forces seen by the chon-
drocytes in the three-dimensional architecture, because
shear stress is reported to release nitrite from articular chon-
drocytes (24).
We further evaluated the effect of hydrocortisone and
TGF-(3, known modulators ofiNOS (5, 25), on OA-NOS
expression in ex vivo conditions. Unlike the effects of cy-
cloheximide and PDTC, there was no significant effect of
10 p,M of hydrocortisone (10.3 ± 4.9) or 2.5 ng/ml of
TGF-P (8.7 ± 2.3) on the spontaneous release of nitrite
(9.6 ± 1 .5 p,M) from OA cartilage in organ cultures,
whereas LPS-stimulated RAW 264.7 cells showed a signif-
icant decrease (6 .4 ± 0.5 and 2 .8 ± 0.7 RM, n = 3;
P<0.001) in nitrite released in the presence of equivalent
amounts of hydrocortisone and TGF-(3, respectively (5,
25) . These experiments show that some of the regulatory
properties of OA-NOS are distinct from iNOS. This may
be because the rodent chondrosarcomas express a 133 kD
iNOS (Amin et al., unpublished data). Although TGF-P and
hydrocortisone may not have a direct effect on OA-NOS
expression, they are known to contribute to chondrogene-
sis and to repair and healing mechanisms in the cartilage
(26) . Furthermore, previous studies by Thorbecke and co-
workers (27) have demonstrated that injecting mice with
TGF-P suppresses collagen-induced arthritis, thus indicat-
ing that the role of TGF-P (other than its ability to suppress
iNOS activity in the rodent system) may also be to suppress
inflammatory processes such as infiltrating T cells. How-
ever, targeting of 133-kD iNOS for pharmacological inter-
vention in animal models of arthritis in vivo, or bovine
chondrocytes in vitro, should proceed with caution, keep-
ing in mind the characteristic features ofhuman OA-NOS.
In summary, articular chondrocytes are a source of in-
creased levels of intraarticular NO that have been specu-
lated in OA patients (8) . Our data further support the no-
tion that NO, a known inflammatory mediator, is released
in sufficient quantities (4, 8) to cause chondrocyte dysfunc-
tion and to damage cartilage integrity, and thus may be one
of the key mediators in the pathogenesis of OA. Further
study ofthe mechanisms governing NOS expression and of
the consequences of increased NO production by OA-
affected cartilage will help to define potential targets for
pharmacological intervention and gene therapy.
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